COPD pharmacology

Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD
Koralia Paschalaki, Christos Rossios, Charis Pericleous, Mairi MacLeod, Stephen Rothery, Gavin C Donaldson, Jadwiga A Wedzicha, Vassilis Gorgoulis, Anna M Randi, Peter J Barnes

Thorax Jan 2022, thoraxjnl-2020-216807; DOI: 10.1136/thoraxjnl-2020-216807
Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study
Matthew J Pavitt, Adam Lewis, Sara C Buttery, Bernadette O Fernandez, Monika Mikus-Lelinska, Winston A S Banya, Martin Feelisch, Michael I Polkey, Nicholas S Hopkinson

Thorax Dec 2021, thoraxjnl-2021-217147; DOI: 10.1136/thoraxjnl-2021-217147
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
Safa Ahmadian, Don D Sin, Larry Lynd, Mark Harrison, Mohsen Sadatsafavi

Thorax Nov 2021, thoraxjnl-2021-217962; DOI: 10.1136/thoraxjnl-2021-217962
Inhaled corticosteroids in COPD: risk and benefits
Christer Janson

Thorax Sep 2021, thoraxjnl-2021-217930; DOI: 10.1136/thoraxjnl-2021-217930
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
Benjamin David, Mona Bafadhel, Leo Koenderman, Antony De Soyza

Thorax Feb 2021, 76 (2) 188-195; DOI: 10.1136/thoraxjnl-2020-215167
Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study
Daniel B Rasmussen, Uffe Bodtger, Morten Lamberts, Christian Torp-Pedersen, Gunnar Gislason, Peter Lange, Magnus T Jensen

Thorax Nov 2020, 75 (11) 928-933; DOI: 10.1136/thoraxjnl-2019-214206
Customer is always right: optimising inhaler design to fit patient preferences in obstructive lung disease
Andrew Gangemi, Victor Kim, Gerard Criner

Thorax Sep 2020, 75 (9) 711-712; DOI: 10.1136/thoraxjnl-2020-215238
Association between COPD exacerbations and lung function decline during maintenance therapy
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken, Janwillem WH Kocks, Mohsen Sadatsafavi, Don D Sin, Victoria Carter, David B Price

Thorax Sep 2020, 75 (9) 744-753; DOI: 10.1136/thoraxjnl-2019-214457
Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study
Matthew J Pavitt, Rebecca Jayne Tanner, Adam Lewis, Sara Buttery, Bhavin Mehta, Helen Jefford, Katrina J Curtis, Winston A S Banya, Syed Husain, Karnan Satkunam, Dinesh Shrikrishna, William Man, Michael I Polkey, Nicholas S Hopkinson

Thorax Jul 2020, 75 (7) 547-555; DOI: 10.1136/thoraxjnl-2019-214278
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
David Smith, Ingrid Du Rand, Charlotte Louise Addy, Timothy Collyns, Simon Paul Hart, Philip J Mitchelmore, Najib M Rahman, Ravijyot Saggu

Thorax May 2020, 75 (5) 370-404; DOI: 10.1136/thoraxjnl-2019-213929

Main menu

COPD pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COPD pharmacology

Pages